Growth momentum Surgical Directions has rapid product expansion activity including the launch of Rapid SPD Diagnostics in 2026 and ongoing Expert Panel Series, signaling a growing demand for perioperative optimization solutions and opportunities to cross-sell analytics, staffing, and workflow improvements to health systems seeking governance and regulatory readiness.

Strategic partnerships Recent collaborations with notable institutions like Boston Children’s Hospital demonstrate a track record of partnering with large healthcare systems to enhance sterile processing and perioperative services, indicating potential for expanded contracts with major academic medical centers and health systems.

Operational focus Distinct emphasis on sterile processing, nurse staffing, and procedural productivity, backed by predictive analytics and a peer-to-peer triad model, suggests cross-sell opportunities in workforce optimization, staffing solutions, and data-driven operational improvements across perioperative domains.

Executive leadership Senior hires in strategy, anesthesia leadership, and operations indicate a growth-driven governance approach, presenting openings for enterprise-wide engagements and advisory services with hospital networks pursuing high-level transformational programs.

Financial health Revenue range of 10 to 25 million places the company in a scalable mid-market tier with potential for services expansion into larger health systems, leveraging proven ROI guarantees to drive new contracts around efficiency gains and cost containment.